Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.
Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ; American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group. Arnett DK, et al. Among authors: boerwinkle e. Circulation. 2007 Jun 5;115(22):2878-901. doi: 10.1161/CIRCULATIONAHA.107.183679. Epub 2007 May 21. Circulation. 2007. PMID: 17515457
Genetics of ultrasonographic carotid atherosclerosis.
Manolio TA, Boerwinkle E, O'Donnell CJ, Wilson AF. Manolio TA, et al. Among authors: boerwinkle e. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1567-77. doi: 10.1161/01.ATV.0000138789.11433.c1. Epub 2004 Jul 15. Arterioscler Thromb Vasc Biol. 2004. PMID: 15256397 Review.
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH. Arnett DK, et al. Among authors: boerwinkle e. Circulation. 2005 Jun 28;111(25):3374-83. doi: 10.1161/CIRCULATIONAHA.104.504639. Epub 2005 Jun 20. Circulation. 2005. PMID: 15967849 Clinical Trial.
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Maitland-van der Zee AH, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Miller MB, Klungel OH, Ford CE, Eckfeldt JH. Maitland-van der Zee AH, et al. Among authors: boerwinkle e. Am Heart J. 2007 Jan;153(1):54-8. doi: 10.1016/j.ahj.2006.10.019. Am Heart J. 2007. PMID: 17174637 Free PMC article.
Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.
Maitland-van der Zee AH, Lynch A, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Ford CE, Eckfeldt JH. Maitland-van der Zee AH, et al. Among authors: boerwinkle e. Pharmacogenet Genomics. 2008 Aug;18(8):651-6. doi: 10.1097/FPC.0b013e3282fe1759. Pharmacogenet Genomics. 2008. PMID: 18622257 Free PMC article. Clinical Trial.
1,413 results